Cargando…

Increased Expression of Tim-3 Is Associated With Depletion of NKT Cells In SARS-CoV-2 Infection

In the ongoing coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), natural killer T (NKT) cells act as primary initiators of immune responses. However, a decrease of circulating NKT cells has been observed in COVID-19 different stages, of which...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jingzhi, Chang, Teding, Tang, Liangsheng, Deng, Hai, Chen, Deng, Luo, Jialiu, Wu, Han, Tang, TingXuan, Zhang, Cong, Li, Zhenwen, Dong, Liming, Yang, Xiang-Ping, Tang, Zhao-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889099/ https://www.ncbi.nlm.nih.gov/pubmed/35250975 http://dx.doi.org/10.3389/fimmu.2022.796682

Ejemplares similares

Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection
por: Chang, Teding, et al.
Publicado: (2022)

Activated autophagy of innate immune cells during the early stages of major trauma
por: Chen, Deng, et al.
Publicado: (2023)

Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19
por: Chen, Shunyao, et al.
Publicado: (2023)

Multifactorial Shock: A Neglected Situation in Polytrauma Patients
por: Luo, Jialiu, et al.
Publicado: (2022)

Venous Thrombus Embolism in Polytrauma: Special Attention to Patients with Traumatic Brain Injury
por: Chen, Deng, et al.
Publicado: (2023)

TIM-4 is expressed on invariant NKT cells but dispensable for their development and function
por: Zhang, Xilin, et al.
Publicado: (2016)

Interleukin-7 Biology and Its Effects on Immune Cells: Mediator of Generation, Differentiation, Survival, and Homeostasis
por: Chen, Deng, et al.
Publicado: (2021)

Invariant NKT cells are more abundant in peanut-allergic adults and a subset of CD8(+) iNKT cells are depleted after peanut oil exposure
por: Hopkins, Georgina V., et al.
Publicado: (2023)

Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies
por: Deng, Hai, et al.
Publicado: (2021)

Tim-3 Relieves Experimental Autoimmune Encephalomyelitis by Suppressing MHC-II
por: Tang, Lili, et al.
Publicado: (2022)

Dynamics of NKT-Cell Responses to Chlamydial Infection
por: Shekhar, Sudhanshu, et al.
Publicado: (2015)

The Role of Autophagy in iNKT Cell Development
por: Yang, Guan, et al.
Publicado: (2018)

Tim-3 Expression Causes NK Cell Dysfunction in Type 2 Diabetes Patients
por: Wang, Hui, et al.
Publicado: (2022)

Editorial: NKT Cells in Cancer Immunotherapy
por: Webb, Tonya J., et al.
Publicado: (2020)

Tim‐3 blockade promotes iNKT cell function to inhibit HBV replication
por: Xu, Yong, et al.
Publicado: (2018)

The structure of Tim50(164–361) suggests the mechanism by which Tim50 receives mitochondrial presequences
por: Li, Jingzhi, et al.
Publicado: (2015)

Ubiquitination and degradation of NF90 by Tim-3 inhibits antiviral innate immunity
por: Dou, Shuaijie, et al.
Publicado: (2021)

Peripheral Injection of Tim-3 Antibody Attenuates VSV Encephalitis by Enhancing MHC-I Presentation
por: Li, Ge, et al.
Publicado: (2021)

NKT Cell Networks in the Regulation of Tumor Immunity
por: Robertson, Faith C., et al.
Publicado: (2014)

NKT Cells as an Ideal Anti-Tumor Immunotherapeutic
por: Fujii, Shin-ichiro, et al.
Publicado: (2013)

Regulation of NKT Cell Localization in Homeostasis and Infection
por: Slauenwhite, Drew, et al.
Publicado: (2015)

iNKT and MAIT Cell Alterations in Diabetes
por: Magalhaes, Isabelle, et al.
Publicado: (2015)

Erratum: Editorial: NKT Cells in Cancer Immunotherapy
Publicado: (2020)

Novel lipid antigens for NKT cells in cancer
por: Lee, Michael S., et al.
Publicado: (2023)

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
por: Fujii, Shin-ichiro, et al.
Publicado: (2018)

Akt2 Regulates the Differentiation and Function of NKT17 Cells via FoxO-1-ICOS Axis
por: Niu, LinLin, et al.
Publicado: (2018)

TIM-3 Regulates Distinct Functions in Macrophages
por: Ocaña-Guzman, Ranferi, et al.
Publicado: (2016)

Tim-4 in Health and Disease: Friend or Foe?
por: Liu, Wen, et al.
Publicado: (2020)

Tissue-Specific Roles of NKT Cells in Tumor Immunity
por: Terabe, Masaki, et al.
Publicado: (2018)

Corrigendum: Akt2 Regulates the Differentiation and Function of NKT17 Cells via FoxO-1-ICOS Axis
por: Niu, LinLin, et al.
Publicado: (2020)

An Emerging Role of TIM3 Expression on T Cells in Chronic Kidney Inflammation
por: Lu, Can, et al.
Publicado: (2022)

Identification and Isolation of Type II NKT Cell Subsets in Human Blood and Liver
por: Yang Zhou, Jordi, et al.
Publicado: (2022)

The Timing and Abundance of IL-2Rβ (CD122) Expression Control Thymic iNKT Cell Generation and NKT1 Subset Differentiation
por: Won, Hee Yeun, et al.
Publicado: (2021)

Type II NKT Cells: An Elusive Population With Immunoregulatory Properties
por: Singh, Avadhesh Kumar, et al.
Publicado: (2018)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
por: Wolf, Benjamin J., et al.
Publicado: (2018)

Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020)

The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells
por: Gerth, Evelyn, et al.
Publicado: (2019)

New insights into iNKT cells and their roles in liver diseases
por: Gu, Xinyu, et al.
Publicado: (2022)

CD8(+) T-cell immunity orchestrated by iNKT cells
por: Qin, Yingyu, et al.
Publicado: (2023)

α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
por: Zhang, Yingting, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h83tupgjlioalrom5edjqfts5e